Icon

SELZENTRY (nda022128)- (25MG,75MG,150MG,300MG)

MARAVIROC VIIV HLTHCARE
25MG,75MG,150MG,300MG
Yes No
2023-May-25 Expired
None None
None No
SELZENTRY is a CCR5 co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic HIV-1 infection in adults and pediatric patients weighing at least 2 kg.
2 1 2
Total Other Developers 5
Drugs with Suitability No
25MG ** ** - - -
75MG ** ** - - -
150MG ** ** Up - 2
300MG ** ** Up - 2
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ****** **** *** *** ****** *************** *** *********** *** ******** **, *********, *** **** (**) *****, ****** ****** (***) ***
****** * * ****** * * ***************, *** *********** *** **** ******, **********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.